BlackRock Health Sciences Term Trust (BMEZ)

BlackRock Health Sciences Term Trust is a closed-end fund that invests mainly in equities of companies in the health sciences industries—pharmaceuticals, biotechnology, medical devices and related life sciences. Managed by BlackRock’s health sciences team, it seeks total return through capital appreciation and income within a defined term structure. The portfolio is concentrated in healthcare innovation and established drug and device makers rather than broad market indexes. It is designed for investors wanting active health-sector equity exposure in a closed-end format.

Market
NYSE
Sector
Financial Services
Trend
Strong uptrend
Last close
16.93 (+0.42% on the day)
MA50
16.47
MA200
14.72
52-week range
13.08–17.02
Market cap
1B USD
P/E
4.81
Dividend yield
0%
Data as of
2026-10-22

All markets — KeepWinning global stock screener

Other companies on NYSE: Universal Corporation (UVV), Tuya Inc. (TUYA), McEwen Inc. (MUX), Centerspace (CSR), Tortoise Energy Infrastructure Corporation (TYG), BlackRock Innovation and Growth Term Trust (BTX)